Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Cancer incidence and mortality rates and trends in Trinidad and Tobago.

Warner WA, Lee TY, Badal K, Williams TM, Bajracharya S, Sundaram V, Bascombe NA, Maharaj R, Lamont-Greene M, Roach A, Bondy M, Ellis MJ, Rebbeck TR, Slovacek S, Luo J, Toriola AT, Llanos AAM.

BMC Cancer. 2018 Jul 4;18(1):712. doi: 10.1186/s12885-018-4625-x.

2.

Hand grip strength and cognitive function among elderly cancer survivors.

Yang L, Koyanagi A, Smith L, Hu L, Colditz GA, Toriola AT, López Sánchez GF, Vancampfort D, Hamer M, Stubbs B, Waldhör T.

PLoS One. 2018 Jun 4;13(6):e0197909. doi: 10.1371/journal.pone.0197909. eCollection 2018.

3.

Adiposity at Age 10 and Mammographic Density among Premenopausal Women.

Alimujiang A, Imm KR, Appleton CM, Colditz GA, Berkey CS, Toriola AT.

Cancer Prev Res (Phila). 2018 May;11(5):287-294. doi: 10.1158/1940-6207.CAPR-17-0309. Epub 2018 Mar 2.

PMID:
29500187
4.

The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.

Jeon CY, Li D, Cleary S, Stolzenberg-Solomon R, Bosetti C, La Vecchia C, Porta M, Toriola AT, Hung RJ, Kurtz RC, Olson SH.

Pancreas. 2018 Mar;47(3):314-320. doi: 10.1097/MPA.0000000000000989.

PMID:
29401167
5.

Increased breast tissue receptor activator of nuclear factor-κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women.

Toriola AT, Dang HX, Hagemann IS, Appleton CM, Colditz GA, Luo J, Maher CA.

Oncotarget. 2017 May 17;8(43):73787-73792. doi: 10.18632/oncotarget.17909. eCollection 2017 Sep 26.

6.

Inflammation Modifies the Association of Obesity with Circulating 25-Hydroxyvitamin D Levels in Cancer Survivors.

Yang L, Toriola AT.

Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S58-S65. doi: 10.1002/oby.22011.

PMID:
29086515
7.

A situational analysis of breast cancer early detection services in Trinidad and Tobago.

Badal K, Rampersad F, Warner WA, Toriola AT, Mohammed H, Scheffel HA, Ali R, Moosoodeen M, Konduru S, Russel A, Haraksingh R.

Cancer Causes Control. 2018 Jan;29(1):33-42. doi: 10.1007/s10552-017-0937-4. Epub 2017 Aug 11.

PMID:
28801763
8.

Adiposity during early adulthood, changes in adiposity during adulthood, attained adiposity, and mammographic density among premenopausal women.

Alimujiang A, Appleton C, Colditz GA, Toriola AT.

Breast Cancer Res Treat. 2017 Nov;166(1):197-206. doi: 10.1007/s10549-017-4384-4. Epub 2017 Jul 12.

PMID:
28702890
10.

Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.

Toriola AT, Ziegler M, Li Y, Pollak M, Stolzenberg-Solomon R.

Ann Surg Oncol. 2017 Oct;24(11):3212-3219. doi: 10.1245/s10434-017-5988-y. Epub 2017 Jul 5.

PMID:
28681154
11.

No Association Between Nonsteroidal Anti-inflammatory Drug Use and Pancreatic Cancer Incidence and Survival.

Lad AA, Ma Y, Lee JA, Park Y, Liao LM, Stolzenberg-Solomon R, Toriola AT.

Pancreas. 2017 May/Jun;46(5):e43-e45. doi: 10.1097/MPA.0000000000000809. No abstract available.

PMID:
28426499
12.

Weight and weight changes in early adulthood and later breast cancer risk.

Rosner B, Eliassen AH, Toriola AT, Chen WY, Hankinson SE, Willett WC, Berkey CS, Colditz GA.

Int J Cancer. 2017 May 1;140(9):2003-2014. doi: 10.1002/ijc.30627.

13.

Is There an Association Between Bone Mineral Density and Mammographic Density? A Systematic Review.

Lee JM, Holley S, Appleton C, Toriola AT.

J Womens Health (Larchmt). 2017 Apr;26(4):389-395. doi: 10.1089/jwh.2016.5769. Epub 2016 Nov 18. Review.

PMID:
27860535
14.

Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.

Fortner RT, Schock H, Kaaks R, Lehtinen M, Pukkala E, Lakso HÅ, Tanner M, Kallio R, Joensuu H, Korpela J, Toriola AT, Hallmans G, Grankvist K, Zeleniuch-Jacquotte A, Toniolo P, Lundin E, Surcel HM.

Cancer Res. 2017 Jan 1;77(1):134-141. doi: 10.1158/0008-5472.CAN-16-1524. Epub 2016 Oct 26.

15.

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.

Nywening TM, Wang-Gillam A, Sanford DE, Belt BA, Panni RZ, Cusworth BM, Toriola AT, Nieman RK, Worley LA, Yano M, Fowler KJ, Lockhart AC, Suresh R, Tan BR, Lim KH, Fields RC, Strasberg SM, Hawkins WG, DeNardo DG, Goedegebuure SP, Linehan DC.

Lancet Oncol. 2016 May;17(5):651-62. doi: 10.1016/S1470-2045(16)00078-4. Epub 2016 Apr 4.

16.

Inflammatory biomarker score and cancer: A population-based prospective cohort study.

Morrison L, Laukkanen JA, Ronkainen K, Kurl S, Kauhanen J, Toriola AT.

BMC Cancer. 2016 Feb 10;16:80. doi: 10.1186/s12885-016-2115-6.

17.

Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and Tobago.

Warner WA, Morrison RL, Lee TY, Williams TM, Ramnarine S, Roach V, Slovacek S, Maharaj R, Bascombe N, Bondy ML, Ellis MJ, Toriola AT, Roach A, Llanos AA.

Cancer Med. 2015 Nov;4(11):1742-53. doi: 10.1002/cam4.503. Epub 2015 Sep 4.

18.

Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors.

Toriola AT, Liu J, Ganz PA, Colditz GA, Yang L, Izadi S, Naughton MJ, Schwartz AL, Wolin KY.

Breast Cancer Res Treat. 2015 Aug;152(3):637-43. doi: 10.1007/s10549-015-3496-y. Epub 2015 Jul 15.

19.

Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study.

Cheng TY, Makar KW, Neuhouser ML, Miller JW, Song X, Brown EC, Beresford SA, Zheng Y, Poole EM, Galbraith RL, Duggan DJ, Habermann N, Bailey LB, Maneval DR, Caudill MA, Toriola AT, Green R, Ulrich CM.

Cancer. 2015 Oct 15;121(20):3684-91. doi: 10.1002/cncr.29465. Epub 2015 Jun 24.

20.

Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women.

Rosner B, Eliassen AH, Toriola AT, Hankinson SE, Willett WC, Natarajan L, Colditz GA.

Breast Cancer Res Treat. 2015 Apr;150(3):643-53. doi: 10.1007/s10549-015-3344-0. Epub 2015 Mar 22.

21.

Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected].

Toriola AT, Fields RC.

Future Oncol. 2014;10(9):1519-22. doi: 10.2217/fon.14.88. No abstract available. Erratum in: Future Oncol. 2014;10(11):1888.

22.

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).

Ulrich CM, Rankin C, Toriola AT, Makar KW, Altug-Teber Ö, Benedetti JK, Holmes RS, Smalley SR, Blanke CD, Lenz HJ.

Cancer. 2014 Nov 1;120(21):3329-3337. doi: 10.1002/cncr.28830. Epub 2014 Jul 15.

23.

Diabetes and pancreatic cancer survival: a prospective cohort-based study.

Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G.

Br J Cancer. 2014 Jul 8;111(1):181-5. doi: 10.1038/bjc.2014.224. Epub 2014 May 1.

24.

Circulating 25-hydroxyvitamin D levels and prognosis among cancer patients: a systematic review.

Toriola AT, Nguyen N, Scheitler-Ring K, Colditz GA.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):917-33. doi: 10.1158/1055-9965.EPI-14-0053. Epub 2014 Apr 1. Review.

25.

Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women.

Abbenhardt C, Miller JW, Song X, Brown EC, Cheng TY, Wener MH, Zheng Y, Toriola AT, Neuhouser ML, Beresford SA, Makar KW, Bailey LB, Maneval DR, Green R, Manson JE, Van Horn L, Ulrich CM.

J Nutr. 2014 May;144(5):714-21. doi: 10.3945/jn.113.183970. Epub 2014 Mar 19.

26.

Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer.

Toriola AT, Tolockiene E, Schock H, Surcel HM, Zeleniuch-Jacquotte A, Wadell G, Toniolo P, Lundin E, Grankvist K, Lukanova A.

Future Oncol. 2014 Feb;10(3):377-84. doi: 10.2217/fon.13.208.

27.

Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.

Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanov D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM.

Pharmacogenet Genomics. 2013 Aug;23(8):428-437. doi: 10.1097/FPC.0b013e3283631784.

28.

Prediagnostic circulating markers of inflammation and risk of prostate cancer.

Toriola AT, Laukkanen JA, Kurl S, Nyyssönen K, Ronkainen K, Kauhanen J.

Int J Cancer. 2013 Dec 15;133(12):2961-7. doi: 10.1002/ijc.28313. Epub 2013 Jul 13.

29.

Trends in breast cancer incidence and mortality in the United States: implications for prevention.

Toriola AT, Colditz GA.

Breast Cancer Res Treat. 2013 Apr;138(3):665-73. doi: 10.1007/s10549-013-2500-7. Epub 2013 Apr 2. Review.

PMID:
23546552
30.

Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels.

Abbenhardt C, McTiernan A, Alfano CM, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Toriola AT, Potter JD, Mason C, Xiao L, Blackburn GL, Bain C, Ulrich CM.

J Intern Med. 2013 Aug;274(2):163-75. doi: 10.1111/joim.12062. Epub 2013 Mar 29. Erratum in: J Intern Med. 2014 Oct;276(4):418.

31.

Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study.

Ulrich CM, Toriola AT, Siegel EM, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush SK, Makar K, Würtele G, Haubner R, Sellers TA, Grady W.

J Nutr Sci. 2013 Apr 9;2:e9. doi: 10.1017/jns.2012.28. eCollection 2013.

32.

Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.

Toriola AT, Cheng TY, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SA, Gunter MJ, Caudill MA, Ulrich CM.

Int J Cancer. 2013 Jun 1;132(11):2648-58. doi: 10.1002/ijc.27942. Epub 2012 Dec 5.

33.

Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women.

Ulrich CM, Toriola AT, Koepl LM, Sandifer T, Poole EM, Duggan C, McTiernan A, Issa JP.

Epigenetics. 2012 Sep;7(9):1020-8. Epub 2012 Aug 7.

34.

Determinants of maternal sex steroids during the first half of pregnancy.

Toriola AT, Vääräsmäki M, Lehtinen M, Zeleniuch-Jacquotte A, Lundin E, Rodgers KG, Lakso HA, Chen T, Schock H, Hallmans G, Pukkala E, Toniolo P, Grankvist K, Surcel HM, Lukanova A.

Obstet Gynecol. 2011 Nov;118(5):1029-36. doi: 10.1097/AOG.0b013e3182342b7f. Erratum in: Obstet Gynecol. 2012 Jan;119(1):186-7.

35.

Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?

Toriola AT, Ulrich CM.

Future Oncol. 2011 Oct;7(10):1125-8. doi: 10.2217/fon.11.92. No abstract available.

PMID:
21992725
36.

Psychosocial problems in childhood and later alcohol consumption: a life course approach with historical information.

Leino J, Kauhanen L, Hokkinen L, Kurl S, Toriola AT, Voutilainen S, Lynch JW, Kauhanen J.

Scand J Public Health. 2011 Nov;39(7):749-56. doi: 10.1177/1403494811421056. Epub 2011 Sep 26.

PMID:
21948991
37.

Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study.

Toriola AT, Surcel HM, Lundin E, Schock H, Grankvist K, Pukkala E, Chen T, Toniolo P, Lehtinen M, Zeleniuch-Jacquotte A, Lukanova A.

Cancer Causes Control. 2011 Nov;22(11):1607-11. doi: 10.1007/s10552-011-9828-2. Epub 2011 Aug 11.

PMID:
21833488
38.

Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer.

Toriola AT, Lundin E, Schock H, Grankvist K, Pukkala E, Chen T, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Surcel HM, Lukanova A.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1798-801. doi: 10.1158/1055-9965.EPI-11-0441. Epub 2011 Jun 15.

39.

Association of serum 25-hydroxyvitamin D (25-OHD) concentrations with maternal sex steroids and IGF-1 hormones during pregnancy.

Toriola AT, Surcel HM, Husing A, Grankvist K, Lakso HA, Schock H, Lundin E, Lehtinen M, Lukanova A.

Cancer Causes Control. 2011 Jun;22(6):925-8. doi: 10.1007/s10552-011-9752-5. Epub 2011 Mar 9.

40.

Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study.

Toriola AT, Grankvist K, Agborsangaya CB, Lukanova A, Lehtinen M, Surcel HM.

Ann Oncol. 2011 Aug;22(8):1916-21. doi: 10.1093/annonc/mdq694. Epub 2011 Feb 3.

PMID:
21292643
41.

Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: joint effect with vitamin D?

Agborsangaya CB, Lehtinen T, Toriola AT, Pukkala E, Surcel HM, Tedeschi R, Lehtinen M.

Eur J Cancer. 2011 Jan;47(1):116-20. doi: 10.1016/j.ejca.2010.07.006. Epub 2010 Aug 4.

PMID:
20691583
42.

Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study.

Toriola AT, Surcel HM, Calypse A, Grankvist K, Luostarinen T, Lukanova A, Pukkala E, Lehtinen M.

Eur J Cancer. 2010 Oct;46(15):2799-805. doi: 10.1016/j.ejca.2010.05.019. Epub 2010 Jun 18.

PMID:
20601305
43.

The impact of alcohol consumption on the risk of cancer among men: a 20-year follow-up study from Finland.

Toriola AT, Kurl S, Dyba T, Laukkanen JA, Kauhanen J.

Eur J Cancer. 2010 Jun;46(9):1488-92. doi: 10.1016/j.ejca.2010.03.035. Epub 2010 May 3.

PMID:
20444594
44.

The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione.

Agborsangaya C, Toriola AT, Grankvist K, Surcel HM, Holl K, Parkkila S, Tuohimaa P, Lukanova A, Lehtinen M.

Nutr Cancer. 2010;62(1):51-7. doi: 10.1080/01635580903191460.

PMID:
20043259
45.

Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.

Agborsangaya CB, Surcel HM, Toriola AT, Pukkala E, Parkkila S, Tuohimaa P, Lukanova A, Lehtinen M.

Eur J Cancer. 2010 Feb;46(3):467-70. doi: 10.1016/j.ejca.2009.11.019.

PMID:
20022237
46.

Serum 25-hydroxyvitamin D and the risk of ovarian cancer.

Toriola AT, Surcel HM, Agborsangaya C, Grankvist K, Tuohimaa P, Toniolo P, Lukanova A, Pukkala E, Lehtinen M.

Eur J Cancer. 2010 Jan;46(2):364-9. doi: 10.1016/j.ejca.2009.08.002. Epub 2009 Aug 25.

PMID:
19713101
47.

Cardiorespiratory fitness, lifestyle factors and cancer risk and mortality in Finnish men.

Laukkanen JA, Pukkala E, Rauramaa R, Mäkikallio TH, Toriola AT, Kurl S.

Eur J Cancer. 2010 Jan;46(2):355-63. doi: 10.1016/j.ejca.2009.07.013. Epub 2009 Aug 13.

PMID:
19683431
48.

Intensity of leisure-time physical activity and cancer mortality in men.

Laukkanen JA, Rauramaa R, Mäkikallio TH, Toriola AT, Kurl S.

Br J Sports Med. 2011 Feb;45(2):125-9. doi: 10.1136/bjsm.2008.056713. Epub 2009 Jul 28.

PMID:
19656766
49.

Does binge drinking increase the risk of lung cancer: results from the Findrink study.

Toriola AT, Kurl S, Laukkanen JA, Kauhanen J.

Eur J Public Health. 2009 Aug;19(4):389-93. doi: 10.1093/eurpub/ckp049. Epub 2009 Apr 15.

PMID:
19369490
50.

Alcohol consumption and risk of colorectal cancer: the Findrink study.

Toriola AT, Kurl S, Laukanen JA, Mazengo C, Kauhanen J.

Eur J Epidemiol. 2008;23(6):395-401. doi: 10.1007/s10654-008-9244-4. Epub 2008 Apr 12.

PMID:
18409007

Supplemental Content

Loading ...
Support Center